TY - JOUR
T1 - Viral hepatitis among drug users in methadone maintenance
T2 - Associated factors, vaccination outcomes, and interventions
AU - Perlman, David C.
AU - Jordan, Ashly E.
AU - McKnight, Courtney
AU - Young, Christopher
AU - Delucchi, Kevin L.
AU - Sorensen, James L.
AU - Des Jarlais, Don C.
AU - Masson, Carmen L.
N1 - Funding Information:
This work was supported by National Institutes on Drug Abuse (RO1 DA020781, RO1 DA020841, P30 DA011041, P50DA009253, and U10DA015815).
Publisher Copyright:
Copyright © 2014 Taylor & Francis Group, LLC.
PY - 2014/10/2
Y1 - 2014/10/2
N2 - Drug users are at high risk of viral Hepatitis A, B, and C. The prevalence of Hepatitis A, Hepatitis B, and Hepatitis C, associated factors, and vaccine seroconversion among drug treatment program participants in a randomized controlled trial of hepatitis care coordination were examined. Of 489 participants, 44 and 47% required Hepatitis A/Hepatitis B vaccinations, respectively; 59% were Hepatitis C positive requiring linkage to care. Factors associated with serologic statuses, and vaccine seroconversion are reported; implications for strategies in drug treatment settings are discussed. Results suggest generalizable strategies for drug treatment programs to expand viral hepatitis screening, prevention, vaccination, and linkage to care.
AB - Drug users are at high risk of viral Hepatitis A, B, and C. The prevalence of Hepatitis A, Hepatitis B, and Hepatitis C, associated factors, and vaccine seroconversion among drug treatment program participants in a randomized controlled trial of hepatitis care coordination were examined. Of 489 participants, 44 and 47% required Hepatitis A/Hepatitis B vaccinations, respectively; 59% were Hepatitis C positive requiring linkage to care. Factors associated with serologic statuses, and vaccine seroconversion are reported; implications for strategies in drug treatment settings are discussed. Results suggest generalizable strategies for drug treatment programs to expand viral hepatitis screening, prevention, vaccination, and linkage to care.
KW - Hepatitis C
KW - Viral hepatitis
KW - methadone maintenance treatment program
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=84920008453&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920008453&partnerID=8YFLogxK
U2 - 10.1080/10550887.2014.969623
DO - 10.1080/10550887.2014.969623
M3 - Article
C2 - 25299236
AN - SCOPUS:84920008453
SN - 1055-0887
VL - 33
SP - 322
EP - 331
JO - Journal of Addictive Diseases
JF - Journal of Addictive Diseases
IS - 4
ER -